EDAP TMS enters LOI for EUR 36M credit facility

EDAP TMS (EDAP) announced execution of a letter of intent for EUR 36 million credit facility with the European Investment Bank. Proceeds from this financing will support the continued expansion of Focal One Robotic HIFU in Focal Therapy, the fastest-growing treatment category for early-stage prostate cancer while accelerating the development of new clinical indications. Pending the signature of the final legal documents, the Credit Facility is expected to close no later than the end of Calendar Year 2025.